LncRNA SAMD12-AS1 Suppresses Proliferation and Migration of Hepatocellular Carcinoma via p53 Signaling Pathway

Table 1

Correlation between lncRNA SAMD12-AS1 expression and clinical characteristics of 32 liver cancer patients.

Characteristic	n	LncRNA SAMD12-AS1 expression	P
Gender
Male	22	3.81 ± 1.13	0.5108
Female	10	3.54 ± 0.89
Age, years
<55	11	3.24 ± 0.75	0.2030
≥55	21	3.66 ± 0.92
TNM stage (the 8th edition)
I-II	19	3.04 ± 0.77	0.0490
III-IV	13	3.84 ± 1.43
Tumor size (cm)
<5	20	3.32 ± 0.87	0.2857
≥5	12	3.67 ± 0.95
Tumor number
1	24	3.47 ± 0.94	0.3893
>1	8	3.83 ± 1.21
AFP (ng/mL)
≤20	11	3.12 ± 0.76	0.0349
>20	21	3.90 ± 1.03
Vascular invasion
Yes	18	3.04 ± 0.83	0.0428
No	14	3.78 ± 1.15
Tumor differentiation
I-II	21	3.19 ± 0.88	0.1700
III-IV	11	3.68 ± 1.04
HBs antigen
Negative	10	2.98 ± 0.79	0.0434
Positive	22	3.81 ± 1.12

Note. AFP, alpha-fetoprotein; the tumor differentiation is based on Edmondson–Steiner classification.